Prevnar
NDC Package 0005-1970-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Prevnar is a . Marketed by Wyeth Pharmaceutical Division Of Wyeth Holdings Llc, A Subsidiary Of Pfizer Inc., this product is identified by NDC 0005-1970 and is authorized under FDA application BLA103905.

Identification & Billing

NDC Package Code
0005-1970-50
Package Description
10 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE (0005-1970-49)
Product Code
11-Digit Billing Format
00005197050

Clinical Specifications

Proprietary Name
Prevnar
Dosage Form
-

Regulatory & Marketing

Labeler Name
Wyeth Pharmaceutical Division Of Wyeth Holdings Llc, A Subsidiary Of Pfizer Inc.
FDA Application #
BLA103905
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
03-01-2000
End Marketing Date
02-28-2011
Listing Expiration
02-28-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0005-1970-50 identifies a specific commercial package of 10 syringe in 1 carton / .5 ml in 1 syringe (0005-1970-49) of Prevnar, labeled by Wyeth Pharmaceutical Division Of Wyeth Holdings Llc, A Subsidiary Of Pfizer Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wyeth Pharmaceutical Division Of Wyeth Holdings Llc, A Subsidiary Of Pfizer Inc. on March 01, 2000. The current certification is valid through February 28, 2011.

How is this Wyeth Pharmaceutical Division Of Wyeth Holdings Llc, A Subsidiary Of Pfizer Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00005197050. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0005-1970-50
11-Digit CMS (5-4-2)
00005-1970-50

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.